Previously, umbilical cord blood stem cells were good for children but now this is safe and effective for adults with blood cancers.
They grew more umbilical cord blood stem cells outside the body then transplanted it into an adult blood cancer patients. They were able to restore a normal of blood cells.
Immune therapy company Gamida Cell produces this umbilical cord blood stem cell treatment known as NiCord, and after more successful trials plan to seek approval from the FDA.
They shorten the time that adult blood cancer patients have a compromised immune system down to 11.5 days.
94 percent of adult patients with blood cancers who received the umbilical cord blood treatment ended up with successful graft procedures within six weeks.
Brian Wang is a prolific business-oriented writer of emerging and disruptive technologies. He is known for insightful articles that combine business and technical analysis that catches the attention of the general public and is also useful for those in the industries. He is the sole author and writer of nextbigfuture.com, the top online science blog. He is also involved in angel investing and raising funds for breakthrough technology startup companies.
He gave the recent keynote presentation at Monte Jade event with a talk entitled the Future for You. He gave an annual update on molecular nanotechnology at Singularity University on nanotechnology, gave a TEDX talk on energy, and advises USC ASTE 527 (advanced space projects program). He has been interviewed for radio, professional organizations. podcasts and corporate events. He was recently interviewed by the radio program Steel on Steel on satellites and high altitude balloons that will track all movement in many parts of the USA.
He fundraises for various high impact technology companies and has worked in computer technology, insurance, healthcare and with corporate finance.
He has substantial familiarity with a broad range of breakthrough technologies like age reversal and antiaging, quantum computers, artificial intelligence, ocean tech, agtech, nuclear fission, advanced nuclear fission, space propulsion, satellites, imaging, molecular nanotechnology, biotechnology, medicine, blockchain, crypto and many other areas.